DBD Posts Q3, Short Interest Eases But Street Stays Cautious

Diebold Nixdorf reported Q3 results on October 28 and the stock reacted with a 3.1% decline, now trading at $66.68, leaving the shares down 1.7% on the week despite a 6.3% gain over the past month.

Short interest has moved notably since the earnings-preview note published yesterday. Positions fell roughly 9.2% over the past week to 8.6% of the free float, down from the 9.5% level flagged pre-print, as some bears covered into or through the release. That is a meaningful reduction but still leaves a sizeable short base. The borrow market remains relaxed on both sides. Availability is running at 292%, well above the 52-week low of 253%, meaning shares to lend far outnumber shares already borrowed. Borrowing costs edged up to 0.77% annualised, about 50% above where they were a month ago, but still firmly in low-fee territory with no sign of squeeze pressure. The ORTEX short score has drifted down from 67.8 a week ago to 66.2 today, suggesting the bearish conviction that built through October is modestly unwinding post-print. Options positioning is similarly unremarkable: the put/call ratio is 0.84, slightly above its 20-day average of 0.62 but less than one standard deviation away. The one data point from alternative data worth noting is retail attention. Wikipedia views are running more than two standard deviations above the stock's own 90-day average, the highest relative attention reading in that window, driven by the earnings release and not, as the dataset's own disclosure notes, a revenue indicator.

The Street remains constructively positioned, though the stock trades at a meaningful discount to published targets. DA Davidson maintained its Buy and $100 target on October 27, the day before the print. Wedbush reiterated Outperform and $100 on October 15. Both targets have sat at $100 since February, when each firm raised from $80 following the company's own guidance upgrade. At $66.68, the implied upside to those targets is around 50%. The valuation looks undemanding: the EV/EBITDA multiple is 5.2x, down slightly over the past month, and the PE stands at 9.9x. Earnings yield ranks in the 92nd percentile of the ORTEX universe and EV/EBIT in the 93rd, making the stock look cheap on a mechanical screen. The short score rank, however, sits in just the 4th percentile, meaning bearish positioning is heavier than nearly all peers on that dimension. The bull case rests on the $790M backlog, 2026 EBITDA guidance of $510M to $535M, and the expectation of free cash flow above 50% of EBITDA, with net leverage at only 1.2x. Bears counter that ATM demand is structurally declining, tariff and FX exposure could erode margins, and the company's thin daily liquidity of around $7M creates overhang risk given that debtholders still control roughly 60% of common shares.

The only prior earnings data point with a price reaction is August's Q2 print, when the stock fell 3.9% on the day and 2.0% over the following five sessions. Today's 3.1% decline on the Q3 print is broadly in line with that pattern. The next scheduled event is November 6, flagged in the data as a further results or conference date.

With short sellers partially retreating post-print but the short score still elevated, the next watch point is whether that covering continues or whether the Q3 detail itself, once digested, gives bears fresh reasons to rebuild positions ahead of November 6.